Description
COMPOUNDED CHEMOTHERAPY MEDICATION
First action · last action
2022-09-30 · 2023-11-21
Transactions
3
First transaction's obligation
$4,347,200
Base + all options value (sum of deltas)
$1,395,136
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2022-09-30+$4,347,200= $4,347,200
- Mod P000012023-09-07-$2,401,042= $1,946,158
- Mod P000022023-11-21-$551,022= $1,395,136
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2022-09-30 | +$4,347,200 | $4,347,200 | COMPOUNDED CHEMOTHERAPY MEDICATION |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-09-07 | −$2,401,042 | $1,946,158 | COMPOUNDED CHEMOTHERAPY MEDICATION |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-11-21 | −$551,022 | $1,395,136 | COMPOUNDED CHEMOTHERAPY MEDICATION |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI K5MHR9JB9ND5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25526N0168 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q517 · PHARMACY SERVICES | $0 | FY2026 |
| 36C26126P0374 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $156,000 | FY2026 |
| 36C24226N0311 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $200,000 | FY2026 |
| 36C24226N0309 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $269,557 | FY2026 |
| 36C26026N0063 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · Q517 · PHARMACY SERVICES | $557 | FY2026 |
| 36C24226N0127 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $20,584 | FY2026 |
Other recipients under 6505 from 262-NETWORK CONTRACT OFFICE 22 (36C262) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26226N0873 | CENTRAL ADMIXTURE PHARMACY SERVICES, INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $140,823 | FY2026 |
| 36C26226N0871 | CENTRAL ADMIXTURE PHARMACY SERVICES, INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $231,746 | FY2026 |
| 36C26226N0870 | CENTRAL ADMIXTURE PHARMACY SERVICES, INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $167,369 | FY2026 |
| 36C26226N0872 | CENTRAL ADMIXTURE PHARMACY SERVICES, INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $164,265 | FY2026 |
| 36C26226P1412 | ASD SPECIALTY HEALTHCARE, LLC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $38,220 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26222P2228_3600_-NONE-_-NONE- · retrieved 2026-09-26.